New study aims to make pain relief safer after abdominal surgery
NCT ID NCT07581275
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looks at how the numbing drug levobupivacaine behaves in the blood after a TAP block, a common pain relief procedure for abdominal surgery. Researchers will take blood samples from 26 adult patients over three hours to measure drug levels. The goal is to find a safe time window to give another painkiller, lidocaine, through an IV without risking side effects.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- levobupivacaine
- What this could lead to
- If successful, this could help doctors safely combine TAP blocks with IV lidocaine for better pain control after abdominal surgery.
- What could go wrong
- This is a small, early observational study with only 26 participants. It does not test any new treatment, so it may not lead to immediate changes in practice.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ABDOMINAL SURGERY PATIENTS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Hospital art program aims to get surgery patients out of bed faster
- Tummy tuck pain relief: nerve block may cut opioid use
- New hospital gown aims to give surgery patients privacy and comfort
- New antifungal drug's belly penetration tested in ICU patients
- New drug formula tested for safety in seniors
- New dissolving migraine pill put to the test in healthy volunteers